GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.10G028600	P00628		1	6.3621942041493e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P00768	Tomentodiplacone B	1	6.11244640176822e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P01505	(2S)-1-[2-[[(2S)-Pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic Acid	1	1.42097427319562e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P01740	Dehydrocycloguanandin	1	8.15904519012643e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P02865	3,4,5-Trihydroxypentanoylcarnitine	1	6.3289033241298e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P08488	Gepotidacin	1	8.66071502689623e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P11224	(Imidazolylbiphenylyl)sulfonylurea	1	3.2712569226805e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P11990	Methyl 18-bromo-5,6-trans-endomethylene-7,11,15-trimethyl-8E,10Z-octadecadien-17-ynoate	1	8.03689829718694e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P12794	(-)-Woodinine	1	1.17462084734417e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P13108	Bms-707035	1	3.64819149652755e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P13824	(2S)-2-Amino-3-[4-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]oxyphenyl]propanoic acid	1	1.42780633489106e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P14214	Decarbamoylgonyautoxin 1	1	8.02989872848183e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P14385	1,2-Dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]phenanthridine	1	7.24807264672201e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P14822	8-Aminoguanosine	1	2.28701292733418e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P17284	Neocalyxin A	1	5.00751509866672e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P18184	Chrotacumine D	1	9.75485786821578e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P19063	L-Arogenate	1	3.79240358133271e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P20589	Norhygrine	1	5.57006800349793e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P20941		1	6.57102449836501e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P21207	Dapriamicin A	1	7.94298210179568e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P22190	1,2,3,4-Tetrahydroisoquinolin-1-yl formate	1	5.01666653491547e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P24143	Porfiromycin	1	1.97808492893764e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P24529	Eterobarb	1	4.85979617507688e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P26160	N-Phenylpropionamide	1	4.05373933378121e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P28189	LysoPS(18:2(9Z,12Z)/0:0)	1	1.17387585166878e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P28394	CDP-DG(i-14:0/20:4(5Z,7E,11Z,14Z)-OH(9))	1	9.63379840255427e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P29314		1	1.17808453796552e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P30039	Tigloylseneganolide A	1	2.82446656256476e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P30440	2-Isopropylfuran	1	3.5278195429808e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P30782	Cryptostigmin IV	1	8.72441706533447e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P30791		1	4.41825915535999e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P31408	Alanditrypinone	1	6.84503473415957e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P31821	Dutasteride	1	4.58802396949662e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P31946	PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0)	1	2.31325871286634e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P34126	1-Nitrohydroxyphenyl-N-benzoylalanine	1	3.57058221749763e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P34868	2-Isopropylfuran	1	3.40507696907199e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P34980	26-O-beta-D-glucopyranosyl-(25R)-furost-5,17-dien-7,26,22-trione-3beta,5alpha,6beta,26-tetrahydroxy-3-O-alpha-l-rhamnopyranosyl-(1-4)-[alpha-l-rhamnopyranosyl-(1-2)]-beta-D-glucopyranoside	1	3.53956556146242e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P35254	Moromycin A	1	3.58509933436511e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P35412	4,5-Dihydro-drospirenone-3-sulfate	1	4.54439167207812e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P36836		1	7.4657725202048e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P37634	Gualamycin	1	2.53791772402801e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P37988		1	4.49987991051403e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P38175	1-hexadecanoyl-2-(9-hydroxy-11-carboxy-10E-undecenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)	1	5.3564931651122e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P38470	Pantoprazole	1	8.96111864518814e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P39845	Celogentin C	1	7.10636012687561e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P41385	Orthosiphol V	1	2.86180606531662e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P43139		1	6.00632277045713e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P43925	(2S)-1-[2-[[(2S)-Pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic Acid	1	9.12660844430281e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P46568	19R-(3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-eicosanoic acid	1	3.67465934217991e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P48055	1-hexadecyl-2-(9Z-nonadecenoyl)-glycero-3-phospho-(1'-sn-glycerol)	1	6.10995823655614e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P48088	3-O-(Z)-Coumaroyl beta-amyrin	1	1.4020338421032e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P48127	2-(13Z-hexadecenoyl)-3-(6'-sulfo-alpha-D-quinovosyl)-sn-glycerol	1	8.01429464431769e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P49120	Leueantine B	1	5.37368379474326e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P52536	3-Hydroxyisorenieratene	1	6.14357267952596e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P52580		1	3.96573044986792e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.10G028600	P53116		1	9.12063577990626e-11	overlap	1e-10	<	Wm82.a2.v1